Evidence map›Paper›PMID 40456971›Full record

ArticleScientific reports2025

Ensemble-based eye disease detection system utilizing fundus and vascular structures.

Hongjie Yu, Xingbo Dong

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Hongjie YuSchool of Communication and Information Engineering, Shanghai University, Shanghai, 200444, China.
Xingbo DongAnhui Provincial International Joint Research Center for Advanced Technology in Medical Imaging, School of Artificial Intelligence, Anhui University, Hefei, 230601, China. xingbo.dong@ahu.edu.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Retinal disorders, posing significant risks of the loss of vision or blindness, are increasingly prevalent, due to factors such as the aging population and chronic conditions like diabetes. Traditional diagnostic methods, relying on manually analyzing images, often have problems making an early detection and with their accuracy and efficiency, largely due to the subjectivity of human judgment and the time-consuming nature of the process. This study introduces a novel AI-based framework for diagnosing retinal disease, referred to as RetinaDNet. This framework leverages dual-branch input, incorporating both retinal images and vessel segmentation images, along with transfer learning and ensemble learning algorithms. This enhances the accuracy of the diagnoses and the stability of the model, particularly in scenarios with small sample sizes. By using vascular features and mitigating the risk of overfitting, this framework demonstrates superior performance in terms of multiple metrics. In particular, a soft voting classifier combined with the ResNet50 model attains accuracy rate of 99.2% on the diabetic retinopathy diagnosis task, and 98.8% on the retina disease classification task. The source code can be accessed at https://github.com/yu0809/Dual-branch-retinal-diseases .

Indexed as

Diabetic RetinopathyFundus OculiRetinal DiseasesRetinal VesselsAlgorithmsHumansImage Processing, Computer-AssistedMachine LearningRetinaBlood vessel segmentationDeep learningDual-branch InputEnsemble learningRetinal disease classification

Identifiers

PMID40456971
PMCPMC12130516

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.